These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impact of post-dilatation on strut apposition of second-generation bioresorbable vascular scaffolds: Key role for scaffold thrombosis and prognosis? Frangieh AH; Jaguszewski M; Imori Y; Obeid S; Templin C Cardiol J; 2018; 25(1):148-150. PubMed ID: 29512102 [No Abstract] [Full Text] [Related]
5. Bioresorbable vascular scaffolds: implication of very late scaffold thrombosis. Mori H; Virmani R; Finn AV Coron Artery Dis; 2017 Nov; 28(7):533-538. PubMed ID: 28692483 [No Abstract] [Full Text] [Related]
6. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent. Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059 [No Abstract] [Full Text] [Related]
7. Very late thrombosis observed on optical coherence tomography 22 months after the implantation of a polymer-based bioresorbable vascular scaffold. Sato T; Abdel-Wahab M; Richardt G Eur Heart J; 2015 May; 36(20):1273. PubMed ID: 25736253 [No Abstract] [Full Text] [Related]
10. Bioresorbable vascular scaffold strut disruption after crossing with an optical coherence tomography imaging catheter. Sato K; Panoulas VF; Naganuma T; Miyazaki T; Latib A; Colombo A Int J Cardiol; 2014 Jul; 174(3):e116-9. PubMed ID: 24814543 [No Abstract] [Full Text] [Related]
11. Restenosis of Coronary Bioresorbable Vascular Scaffolds. Alfonso F; García-Guimaraes M Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):527-531. PubMed ID: 28285939 [No Abstract] [Full Text] [Related]
12. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation. Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457 [No Abstract] [Full Text] [Related]
13. Early disarticulation of a bioresorbable vascular scaffold: an underreported consequence of repeat imaging. Giblett JP; Brown AJ; Hoole SP; West NEJ Cardiovasc Interv Ther; 2018 Apr; 33(2):175-177. PubMed ID: 28275974 [No Abstract] [Full Text] [Related]
14. Bioresorbable vascular scaffolds in coronary bifurcation lesions: The next frontiers? Leesar MA Catheter Cardiovasc Interv; 2016 Nov; 88(6):870-871. PubMed ID: 27886452 [No Abstract] [Full Text] [Related]
15. Very late bioresorbable vascular scaffold thrombosis due to late device recoil. Cortese B; Piraino D; Ielasi A; Steffenino G; Orrego PS Int J Cardiol; 2015; 189():132-3. PubMed ID: 25889443 [No Abstract] [Full Text] [Related]
16. How should I treat a bioresorbable vascular scaffold edge restenosis and intra-scaffold dissection? Fallesen CO; Antonsen L; Thayssen P; Jensen LO; Lee PH; Lee SW; Park SJ; Moscarella E; Spitaleri G; Brugaletta S EuroIntervention; 2018 Feb; 13(14):1730-1734. PubMed ID: 29465408 [No Abstract] [Full Text] [Related]
17. Bioresorbable Vascular Scaffold Technology Benefits From Healthy Skepticism. Cassese S; Kastrati A J Am Coll Cardiol; 2016 Mar; 67(8):932-935. PubMed ID: 26916482 [No Abstract] [Full Text] [Related]
18. Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients. Tröbs M; Achenbach S; Röther J; Klinghammer L; Schlundt C Catheter Cardiovasc Interv; 2016 Nov; 88(6):872-880. PubMed ID: 27142643 [TBL] [Abstract][Full Text] [Related]
19. Late-acquired scaffold malapposition and discontinuity that may be attributable to pathological coronary ectasia: Insights from optical coherence tomography. Miyazaki T; Ruparelia N; Kawamoto H; Sato K; Latib A; Colombo A Int J Cardiol; 2015; 186():136-8. PubMed ID: 25818756 [No Abstract] [Full Text] [Related]